At its simplest, biotechnology is technology based on biology – but Common products such as beer and wine, laundry detergent, and anything made of plastic are all biotechnology products. Humans have employed biotechnology since ancient times to breed animals and improve their crops.
However, in the modern financial world, biotechnology companies comprise an industry sector collectively known as biotech. These companies research, develop, and produce a wide variety of commercial products, though most focus on either medical or agricultural applications.
Biotechnology firms use living organisms as they manufacture products or solve problems. The identification and sourcing of DNA have helped the industry make great leaps. Companies in this sector have developed pest-resistant crops, created biofuels like ethanol, and developed gene cloning.
As the Prime Minister, Alexander De Croo, said, we need to make Belgium the Health and Biotech Valley of the future. That’s the joint ambition of the Belgian government, industry partners and academia.
Already in 2018, the Belgian Business newspaper De Tijd wrote that “Belgian biotech companies such as Biocartis, Galapagos, Argenx, Celyad, MDxHealth and many others are conquering the world.” In the same year, Sanofi’s acquisition of the biotech company Ablynx at 3.9 billion euros and Gilead’s 5.1 billion partnership with Galapagos one year later have reinforced Belgium’s reputation as a European leader in life sciences innovation.
Belgium has a unique ecosystem that covers the entire value chain: from preclinical research for cutting-edge biotech production to the logistics platform for global distribution. As illustration a few figures: Biopharma companies in Belgium account for 18% of the European biotech market capitalization and 7 out of 10 of the cash generating biotech companies in Europe are Belgium.
Innovate Biotech Belgium will showcase how this industry impacts on society. Innovate Biotech Belgium is aimed at local, regional and international business leaders, governments, academics and decision makers influencing the landscape for years to come.
Summarizing: Innovate Biotech Belgium will connect the industry decision makers worldwide as well as accelerate the exchange of vital industry information on investment, best practice, innovation and social responsibility.
Nominations are now open and this is your chance to help showcase the innovators that you know, to the world! Nominate a deserving company or person to be featured in INNOVATE™ Biotech Belgium using the link below:
Freddy Arnauts is a native of Antwerp (Belgium) and has spent most of his life in the Pharmaceutical/Medical world.. With a MSc in Applied Economics and a PhD in Business Administration, he has spearheaded integrated care systems for diabetes, stroke, schizophrenia and epilepsy patients, led numerous European projects in the health sector, and directed Professional affairs and communications within the strategic group marketing for Johnson & Johnson.
Email [email protected] to find out more!